eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing

Han-Han Zhang1, Ran Li2, You-Jie Li3

  • 1Core Laboratory Glycobiol and Glycoengn, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.

Oncology Reports
|January 3, 2020
PubMed

Insights

MicroRNAs miR-320a and miR-340-5p suppress endometrial cancer (EC) metastasis by downregulating the oncogene eukaryotic translation initiation factor 4E (eIF4E). These microRNAs inhibit cell migration and invasion, offering potential therapeutic targets for EC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Endometrial cancer (EC) metastasis is a primary cause of treatment failure.
  • Eukaryotic translation initiation factor 4E (eIF4E), an oncogene, is overexpressed in various cancers, including EC, correlating with poor prognosis.
  • MicroRNAs (miRNAs) are implicated in cancer development, with some acting as tumor suppressors.

Purpose of the Study:

  • To investigate the role of eIF4E, miR-320a, and miR-340-5p in endometrial cancer.
  • To determine the relationship between eIF4E expression and EC prognosis and grade.
  • To elucidate the mechanism by which miR-320a and miR-340-5p affect EC cell behavior and metastasis.

Main Methods:

  • Analysis of microarray data from the Oncomine database for eIF4E expression in EC.
  • Quantitative analysis of miR-320a and miR-340-5p expression in EC tissues.
  • In vitro studies involving miRNA transfection in EC cells (HEC-1A) to assess effects on migration, invasion, and gene expression.
  • Western blot analysis to detect eIF4E and phosphorylated eIF4E (p-eIF4E) levels.
  • Assessment of matrix metallopeptidase (MMP)-3 and MMP-9 expression.
  • Investigation of the interaction with transforming growth factor β1 (TGF-β1) signaling and epithelial-mesenchymal transition (EMT).

Main Results:

  • High eIF4E expression was associated with poor prognosis and higher pathological grade in EC.
  • eIF4E expression was significantly upregulated in EC tissues compared to normal tissues.
  • miR-320a and miR-340-5p were downregulated in EC tissues.
  • Overexpression of miR-320a or miR-340-5p reduced EC cell migration and invasion by downregulating eIF4E, p-eIF4E, MMP-3, and MMP-9.
  • These miRNAs inhibited TGF-β1-induced EMT and p-eIF4E phosphorylation.

Conclusions:

  • eIF4E is upregulated in EC and linked to adverse outcomes.
  • miR-320a and miR-340-5p act as tumor suppressors in EC by targeting eIF4E.
  • These miRNAs inhibit EC cell metastasis and EMT, suggesting their potential as therapeutic agents.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.8K